Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy.

John Devin PeipertSusan E YountFabio EfficaceChristina LoefgrenRenee PiersonJianming HeDavid Cella

Published in: Cancer (2020)

The FACT-Leu is a suitable outcome measure for AML clinical trials among patients not eligible for intensive therapy, and it may have value for clinical monitoring.

Keyphrases

acute myeloid leukemia
cancer therapy
clinical trial
allogeneic hematopoietic stem cell transplantation
drug delivery
randomized controlled trial
mesenchymal stem cells
cell therapy
replacement therapy
double blind